USD
+$0.00
(+0.00%
)At Close (As of Sep 16, 2025)
$385.76M
Market Cap
-
P/E Ratio
-3.16
EPS
$18.62
52 Week High
$6.32
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$306K |
Total Revenue | $0 |
Cost Of Revenue | $306K |
Costof Goods And Services Sold | $306K |
Operating Income | -$197M |
Selling General And Administrative | $53M |
Research And Development | $143M |
Operating Expenses | $197M |
Investment Income Net | - |
Net Interest Income | $30M |
Interest Income | $30M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $306K |
Income Before Tax | -$167M |
Income Tax Expense | $117K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$168M |
Comprehensive Income Net Of Tax | - |
Ebit | -$167M |
Ebitda | -$167M |
Net Income | -$167M |
Field | Value (USD) |
---|---|
Total Assets | $622M |
Total Current Assets | $415M |
Cash And Cash Equivalents At Carrying Value | $83M |
Cash And Short Term Investments | $83M |
Inventory | - |
Current Net Receivables | $3M |
Total Non Current Assets | $207M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | $204M |
Short Term Investments | $316M |
Other Current Assets | $13M |
Other Non Current Assets | - |
Total Liabilities | $31M |
Total Current Liabilities | $31M |
Current Accounts Payable | $1.7M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $2.6M |
Total Non Current Liabilities | $849K |
Capital Lease Obligations | $2.2M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $2.2M |
Other Current Liabilities | $26M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $590M |
Treasury Stock | - |
Retained Earnings | -$368M |
Common Stock | $6K |
Common Stock Shares Outstanding | $54M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$145M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $306K |
Capital Expenditures | $0 |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | -$136M |
Cashflow From Financing | $266M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$168M |
Field | Value (USD) |
---|---|
Gross Profit | -$306K |
Total Revenue | $0 |
Cost Of Revenue | $306K |
Costof Goods And Services Sold | $306K |
Operating Income | -$197M |
Selling General And Administrative | $53M |
Research And Development | $143M |
Operating Expenses | $197M |
Investment Income Net | - |
Net Interest Income | $30M |
Interest Income | $30M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $306K |
Income Before Tax | -$167M |
Income Tax Expense | $117K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$168M |
Comprehensive Income Net Of Tax | - |
Ebit | -$167M |
Ebitda | -$167M |
Net Income | -$167M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Cullinan Management, Inc., a biopharmaceutical company, is focused on developing a line of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company is headquartered in Cambridge, Massachusetts.